DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06990 SKB BIO-B

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders Sichuan Kelun Pharmaceutical Co., Ltd. (66.28%)
Merck & Co., Inc. (5.77%)		 Sector Health Care & Biotechnology
Web Site https://www.kelun-biotech.com Tel N/A
Email klbio_ir@kelun.com Fax N/A
Related Equities N/A
Principal Activities Mainly engaged in researching and developing ('R&D') service, manufacturing and commercialization of novel drugs.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top